News About: Pharm. Industry
Delegation of Hessen, Germany, visited M Lab in Song-do
In order to promote cooperation for investment and strengthen relationship between Korean and German medium-sized companies, the delegation of Hessen, consisting of the vice president of Hessen(minister of economy, en...
Pharmas on emergency to meet their sales goals under impact of Kim Young-Ran Law
At the end of the year, pharmaceutical companies have put on emergency to meet their sales goals.
It is ordinary for pharmaceutical companies to compete over sales in the period. Pharmaceutical companies which receiv...
Why the Korea-multinational open innovation sharing event ‘KPAC’ was delayed?
The ‘Korea Pharma Associations Conference(KPAC),’ which has played a catalyst role the global pharmaceutical companies’ ‘Open Innovation’ cooperation strategy and global partnerships, is delayed.
According to the in...
Kolon Life Science succeeds in exporting ‘Invossa’ technology for KRW 500 billionKolon Life Science(CEO Woo-Seok Lee) will export technology of the world’s first cell and gene therapy for degenerative arthritis, ‘Invossa,’ to Japan. This is the result of Inv...
|
CKD’s sales performance stands out among Big 5 pharmas
It was observed the 3rd quarter’s sales performance of Chong Kun Dang(CKD) stood out compared to the ‘Big 5’ pharmaceutical companies.
According to the analysis result of 2016’s sales performances tentatively aggrega...
How will list pharmas’ ‘sales ranking’ & ‘KRW 1 trillion club’ be?
While the industry has paid attention to the pharmaceutical companies’ final sales ranking as their 3rd quarter’s sales records are released, which pharmaceutical companies will achieve KRW 1 trillion sales are gettin...
‘Self-sufficient rate’ keeps dropping as Korea’s drug competitiveness falls
It was observed the Korea’s self-sufficiency rate in finished drug is getting lower, and the self-sufficiency rate in pharmaceutical ingredient is increasing.
According to the ‘2016 Food and Drug Statistics Annual R...
Active start on export of Celltrion’s antibody biosimilar Remsima to U.S.A Celltrion’s affiliate, Celltrion Healthcare announced it will begin to export Remsima(U.S. product name: Inflectra) from its release data on November.
Through its joint news ...
|
Boehringer acquires Korean approval of IPF treatment ‘Ofev’Boehringer Ingelheim Korea(CEO Ki-Hwan Park) announced acquisition of product approval for its idiopathic pulmonary fibrosis(IPF) treatment, Ofev Soft Cap(generic name: nintedan...
|
Pharma industry about Kim Young-Ran Law, “Company’s excessive pressure causes adverse effect”
The 28th of October will be the day the Kim Young-Ran Law has been enforced for a month.
Known as the ‘Bribery Prohibition Law,’ the law, which has brought both positive and negative impacts across the nation, has al...
